This phase I trial is to find out the best dose, possible benefits and/or side effects of engineered natural killer (NK) cells containing deleted TGF-betaR2 an…

Recurrent GliosarcomaRecurrent Supratentorial GlioblastomaSupratentorial Gliosarcoma

~Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT04991870

Phase 2

Randomized Phase 2 Clinical Trial of Repeated Intratumoral and Cervical Perilymphatic Lerapolturev Injections Versus Lomustine in Recurrent Glioblastoma (GBM)

The purpose of this research study is to determine the safety and efficacy of administering two doses of lerapolturev in residual disease (within tumor margins…

Recurrent Supratentorial Glioblastoma

~Estimated

~$10 – $7,500

Darell BignerNCT06177964